| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14effe3850d2129f863b969dac4f1db8 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-18 |
| filingDate |
1978-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1983-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caf1e47047f26dd91e3fe07c7df07860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dcd893ce893a0bbbc361f33c467f992 |
| publicationDate |
1983-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1140923-A |
| titleOfInvention |
Antitumor agents |
| abstract |
ABSTRACT OF THE DISCLOSURE This disclosure describes symmetrical 1,4-bis-(substituted-amino)-5,8-dihydroxyanthraquinones useful as chelating agents and for inhibiting the growth of transplanted mouse tumors. |
| priorityDate |
1977-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |